These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38498096)

  • 1. The Ribonuclease ZC3H12A is required for self-inflicted DNA breaks after DNA damage in small cell lung cancer cells.
    Lu M; Gao Q; Jin R; Gu M; Wang Z; Li X; Li W; Wang J; Ma T
    Cell Oncol (Dordr); 2024 Aug; 47(4):1497-1502. PubMed ID: 38498096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-138 Regulates DNA Damage Response in Small Cell Lung Cancer Cells by Directly Targeting H2AX.
    Yang H; Luo J; Liu Z; Zhou R; Luo H
    Cancer Invest; 2015 Apr; 33(4):126-36. PubMed ID: 25699650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.
    Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T
    Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK228 sensitizes radioresistant small cell lung cancer cells to radiation.
    Li H; Ma L; Bian X; Lv Y; Lin W
    Clin Epigenetics; 2021 Feb; 13(1):41. PubMed ID: 33632300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wee1 epigenetically modulates H2B mono-ubiquitination at K120 lysine and DNA double-strand break repair through phosphorylation of H2BY37-dependent manner in small-cell lung cancer.
    Zhao X; Wen X; Liu B
    Thorac Cancer; 2023 Jun; 14(16):1420-1429. PubMed ID: 37102239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
    Kanteti R; Nallasura V; Loganathan S; Tretiakova M; Kroll T; Krishnaswamy S; Faoro L; Cagle P; Husain AN; Vokes EE; Lang D; Salgia R
    Lab Invest; 2009 Mar; 89(3):301-14. PubMed ID: 19139719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
    Allison Stewart C; Tong P; Cardnell RJ; Sen T; Li L; Gay CM; Masrorpour F; Fan Y; Bara RO; Feng Y; Ru Y; Fujimoto J; Kundu ST; Post LE; Yu K; Shen Y; Glisson BS; Wistuba I; Heymach JV; Gibbons DL; Wang J; Byers LA
    Oncotarget; 2017 Apr; 8(17):28575-28587. PubMed ID: 28212573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer.
    Huang QM; Tomida S; Masuda Y; Arima C; Cao K; Kasahara TA; Osada H; Yatabe Y; Akashi T; Kamiya K; Takahashi T; Suzuki M
    Cancer Res; 2010 Nov; 70(21):8407-16. PubMed ID: 20861182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer.
    Sun BB; Wang GZ; Han SC; Yang FY; Guo H; Liu J; Liu YT; Zhou GB
    Cancer Lett; 2024 Jun; 592():216929. PubMed ID: 38697461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown GTSE1 enhances radiosensitivity in non-small-cell lung cancer through DNA damage repair pathway.
    Lei X; Du L; Zhang P; Ma N; Liang Y; Han Y; Qu B
    J Cell Mol Med; 2020 May; 24(9):5162-5167. PubMed ID: 32202046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-195 Promotes Small Cell Lung Cancer Cell Apoptosis via Inhibiting Rap2C Protein-Dependent MAPK Signal Transduction.
    Tong J; Lu J; Yin Y; Wang Y; Zhang K
    Technol Cancer Res Treat; 2020; 19():1533033820977546. PubMed ID: 33302819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression.
    Luszczek W; Cheriyath V; Mekhail TM; Borden EC
    Mol Cancer Ther; 2010 Aug; 9(8):2309-21. PubMed ID: 20682643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer.
    Sen T; Tong P; Diao L; Li L; Fan Y; Hoff J; Heymach JV; Wang J; Byers LA
    Clin Cancer Res; 2017 Oct; 23(20):6239-6253. PubMed ID: 28698200
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
    Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway.
    Li L; Song W; Yan X; Li A; Zhang X; Li W; Wen X; Zhou L; Yu D; Hu JF; Cui J
    Oncotarget; 2017 Jun; 8(26):41975-41987. PubMed ID: 28410216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-1 attenuates cisplatin-induced gammaH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer.
    Jeon JH; Kim SK; Kim HJ; Chang J; Ahn CM; Chang YS
    Cancer Lett; 2008 Dec; 272(2):232-41. PubMed ID: 18762365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo deoxyribonucleotide biosynthesis regulates cell growth and tumor progression in small-cell lung carcinoma.
    Maruyama A; Sato Y; Nakayama J; Murai J; Ishikawa T; Soga T; Makinoshima H
    Sci Rep; 2021 Jun; 11(1):13474. PubMed ID: 34188151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer.
    Zhang J; Liu X; Hou P; Lv Y; Li G; Cao G; Wang H; Lin W
    Cell Death Dis; 2024 Jul; 15(7):551. PubMed ID: 39085197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2.
    Niu Y; Ma F; Huang W; Fang S; Li M; Wei T; Guo L
    Mol Cancer; 2017 Jan; 16(1):5. PubMed ID: 28069000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.
    Udyavar AR; Hoeksema MD; Clark JE; Zou Y; Tang Z; Li Z; Li M; Chen H; Statnikov A; Shyr Y; Liebler DC; Field J; Eisenberg R; Estrada L; Massion PP; Quaranta V
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S1. PubMed ID: 24564859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.